Scaleable synthesis of a GPR40 agonist

被引:0
|
作者
Fenster, Michael D. B. [1 ]
Ronald, Hanson L. [1 ]
Katipally, Kishta [1 ]
Paul, Tapas [2 ]
Rao, Ramana [2 ]
Simmons, Eric M. [1 ]
Young, Ian S. [1 ]
Zhu, Jason J. [1 ]
机构
[1] Bristol Myers Squibb Co, Dept Chem Dev, New Brunswick, NJ 08903 USA
[2] Syngene Int Ltd, Bangalore, Karnataka, India
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
119-ORGN
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Development of a Scalable Synthesis of a GPR40 Receptor Agonist
    Walker, Shawn D.
    Borths, Christopher J.
    DiVirgilio, Evan
    Huang, Liang
    Liu, Pingli
    Morrison, Henry
    Sugi, Kiyoshi
    Tanaka, Masahide
    Woo, Jacqueline C. S.
    Faul, Margaret M.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (03) : 570 - 580
  • [2] Lead GPR40 agonist bites the dust
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (02) : 91 - 91
  • [3] Lead GPR40 agonist bites the dust
    Nature Reviews Drug Discovery, 2014, 13 : 91 - 91
  • [4] Evolution of the Synthetic Process to an Advanced GPR40 Agonist
    Hou, Xiaoping
    Hernandez, Lucas W.
    Jurica, Elizabeth A.
    Zhao, Rulin
    Wang, Bei
    Wong, Michael
    Sun, Jung-Hui
    Sun, Dawn
    Wu, Dauh-Rurng
    Yuan, Changxia
    Hay, Michael
    Yu, Miao
    Wu, Ximao
    Huang, Yanting
    Ellsworth, Bruce A.
    Bobes, Francisco Gonzalez
    Mathur, Arvind
    Kempson, James
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2024, 28 (01) : 310 - 324
  • [5] Discovery of a novel potent GPR40 full agonist
    Meegalla, Sanath K.
    Huang, Hui
    Martin, Tonya
    Xu, June
    Zhao, Shuyuan
    Liu, Jianying
    Hall, Meghan
    Gunnet, Joe
    Wang, Yuanping
    Rady, Brian
    Silva, Jose
    Otieno, Monicah
    Arnoult, Eric
    Lee, S. Paul
    Pocai, Alessandro
    Player, Mark R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (04) : 720 - 726
  • [6] AMG 837: A potent, orally bioavailable GPR40 agonist
    Houze, Jonathan B.
    Zhu, Liusheng
    Sun, Ying
    Akerman, Michelle
    Qiu, Wei
    Zhang, Alex J.
    Sharma, Rajiv
    Schmitt, Michael
    Wang, Yingcai
    Liu, Jiwen
    Liu, Jingian
    Medina, Julio C.
    Reagan, Jeff D.
    Luo, Jian
    Tonn, George
    Zhang, Jane
    Lu, Jenny Ying-Lin
    Chen, Michael
    Lopez, Edwin
    Nguyen, Kathy
    Yang, Li
    Tang, Liang
    Tian, Hui
    Shuttleworth, Steven J.
    Lin, Daniel C. -H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1267 - 1270
  • [7] Identification of residues important for agonist recognition and activation in GPR40
    Sum, Chi Shing
    Tikhonova, Irina G.
    Neumann, Susanne
    Engel, Stanislav
    Raaka, Bruce M.
    Costanzi, Stefano
    Gershengorn, Marvin C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (40) : 29248 - 29255
  • [8] Development of a Suitable Salt Form for a GPR40 Receptor Agonist
    Morrison, Henry
    Jona, Jonan
    Walker, Shawn D.
    Woo, Jacqueline C. S.
    Li, Lan
    Fang, Jan
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (01) : 104 - 111
  • [9] Identification of Berberine as a Novel Agonist of Fatty Acid Receptor GPR40
    Rayasam, Geetha Vani
    Tulasi, Vamshi Krishna
    Sundaram, Sindhuja
    Singh, Winny
    Kant, Rajiv
    Davis, Joseph Alex
    Saini, Kulvinder Singh
    Ray, Abhijit
    PHYTOTHERAPY RESEARCH, 2010, 24 (08) : 1260 - 1263
  • [10] Design and Synthesis of Novel, Selective GPR40 AgoPAMs
    Plummer, Christopher W.
    Clements, Matthew J.
    Chen, Helen
    Rajagopalan, Murali
    Josien, Hubert
    Hagmann, William K.
    Miller, Michael
    Trujillo, Maria E.
    Kirkland, Melissa
    Kosinski, Daniel
    Mane, Joel
    Pachanski, Michele
    Cheewatrakoolpong, Boonlert
    Nolting, Andrew F.
    Orr, Robert
    Christensen, Melodie
    Campeau, Louis-Charles
    Wright, Michael J.
    Bugianesi, Randal
    Souza, Sarah
    Zhang, Xiaoping
    Di Salvo, Jerry
    Weinglass, Adam B.
    Tschirret-Guth, Richard
    Nargund, Ravi
    Howard, Andrew D.
    Colletti, Steven L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (02): : 221 - 226